Skip to main content

Table 3 Linear regression analysis between clinicopathologic characteristics and mRNA expression count of SLC7A3, SLC7A5, and SLC7A11 genes

From: Upregulation of the solute carrier family 7 genes is indicative of poor prognosis in papillary thyroid carcinoma

Clinical features SLC7A3 SLC7A5 SLC7A11
t value P value t value P value t value P value
Age 0.76 0.45 − 1.61 0.11 − 1.04 0.30
Tumor size 0.49 0.63 − 0.95 0.34 − 0.51 0.61
Gender (male) 3.18 0.00 0.93 0.35 − 1.34 0.18
Thyroiditis −0.92 0.36 0.61 0.54 1.17 0.24
ETE 2.17 0.03 0.85 0.39 − 1.62 0.11
AJCC stage 2.69 0.01 − 1.01 0.31 − 2.06 0.04
BRAF mutation − 1.49 0.14 0.42 0.67 − 0.92 0.36
RAS mutation − 2.41 0.02 − 1.89 0.06 0.48 0.63
Mortality 2.39 0.02 2.02 0.04 1.65 0.10